NeuroMetrix (NURO) Reports a Miss on Q2 Revenues
Get Alerts NURO Hot Sheet
Join SI Premium – FREE
NeuroMetrix (NASDAQ: NURO) reported revenue for the second quarter came in at $4.3 million versus the consensus estimate of $4.39 million.
- Revenue of $4.3M is up 63% year-over-year
- Quell device shipments of 20.1K and electrode reorders of 30.7K represent new quarterly highs
- DPNCheck revenue of $0.8 million is up 78% year-over-year
For earnings history and earnings-related data on NeuroMetrix (NURO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- Commercial Vehicle Group (CVGI) Tops Q3 EPS by 2c; offers guidance
- Neurocrine Biosciences (NBIX) Tops Q3 EPS by 138c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share